GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Edap TMS SA (NAS:EDAP) » Definitions » Debt-to-EBITDA

Edap TMS (Edap TMS) Debt-to-EBITDA : -0.53 (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Edap TMS Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Edap TMS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $5.58 Mil. Edap TMS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $3.61 Mil. Edap TMS's annualized EBITDA for the quarter that ended in Dec. 2023 was $-17.31 Mil. Edap TMS's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.53.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Edap TMS's Debt-to-EBITDA or its related term are showing as below:

EDAP' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -29.06   Med: 3.53   Max: 26.11
Current: -0.42

During the past 13 years, the highest Debt-to-EBITDA Ratio of Edap TMS was 26.11. The lowest was -29.06. And the median was 3.53.

EDAP's Debt-to-EBITDA is ranked worse than
100% of 75 companies
in the Medical Distribution industry
Industry Median: 1.87 vs EDAP: -0.42

Edap TMS Debt-to-EBITDA Historical Data

The historical data trend for Edap TMS's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edap TMS Debt-to-EBITDA Chart

Edap TMS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.05 10.84 3.49 -29.06 -0.46

Edap TMS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.09 -0.21 -0.31 -0.24 -0.53

Competitive Comparison of Edap TMS's Debt-to-EBITDA

For the Medical Distribution subindustry, Edap TMS's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edap TMS's Debt-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Edap TMS's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Edap TMS's Debt-to-EBITDA falls into.



Edap TMS Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Edap TMS's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.575 + 3.612) / -20.052
=-0.46

Edap TMS's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.575 + 3.612) / -17.312
=-0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Edap TMS  (NAS:EDAP) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Edap TMS Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Edap TMS's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Edap TMS (Edap TMS) Business Description

Traded in Other Exchanges
Address
Parc d'Activites La Poudrette-Lamartine, 4/6, rue du Dauphine, Vaulx-en-Velin, FRA, 69120
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.